Stay updated on Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial

Sign up to get notified when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T16:52:16.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:07:13.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added revision label v3.4.2 and removed the funding-status notice and older revision v3.4.1. These changes are metadata only and do not alter study details or participation information.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:59.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page with guidance to opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0 reference.
    Difference
    0.5%
    Check dated 2026-02-04T00:36:31.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now includes UI/metadata updates: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T23:43:28.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Locations section now includes Wisconsin as a study site. The HHS Vulnerability Disclosure link was removed from the footer, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:09:15.000Z thumbnail image

Stay in the know with updates to Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.